Catalent Inc Human Resources Contracts & Agreements
60 Contracts & Agreements
- Bonus & Incentive Agreements (42 contracts)
- Compensation Agreements (5)
- Employment Agreements (9)
- Retention Agreements (2)
- Severance Agreements (2)
- Form Retention Agreement (Filed With SEC on May 29, 2024)
- Employment Agreement, dated August 28, 2023, between John Greisch and Catalent, Inc (Filed With SEC on May 8, 2024)
- Amendment No. 1 to Catalent, Inc. 2018 Omnibus Incentive Plan (Filed With SEC on January 26, 2024)
- Employment Agreement, dated October 8, 2019, by and between Catalent Pharma Solutions GmbH and Manja Boerman (Filed With SEC on December 8, 2023)
- Form of Severance Agreement between non-US-based executive officers and Catalent Pharma Solutions, Inc (Filed With SEC on December 8, 2023)
- Form of Severance Agreement between US-based executive officers and Catalent Pharma Solutions, Inc (Filed With SEC on December 8, 2023)
- Form of 2018 Omnibus Incentive Plan Performance Share Unit Agreement for Employees (Filed With SEC on December 8, 2023)
- Form of 2018 Omnibus Incentive Plan Option Agreement for Employees (Filed With SEC on December 8, 2023)
- Form of 2018 Omnibus Incentive Plan Restricted Stock Unit Agreement for Employees (Filed With SEC on December 8, 2023)
- Form of 2018 Omnibus Incentive Plan Performance Share Unit Agreement for Non-U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)
- Form of 2018 Omnibus Incentive Plan Performance Share Unit Agreement for U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)
- Form of 2018 Omnibus Incentive Plan Option Agreement for non-U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)
- Form of 2018 Omnibus Incentive Plan Option Agreement for U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)
- Form of 2018 Omnibus Incentive Plan Restricted Stock Unit Agreement for non-U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)
- Form of 2018 Omnibus Incentive Plan Restricted Stock Unit Agreement for U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)
- Catalent Pharma Solutions, Inc. Deferred Compensation Plan, as amended and restated effective October 1, 2022 (Filed With SEC on November 1, 2022)
- Management Incentive Plan Summary for the fiscal year ending June 30, 2023 (Filed With SEC on November 1, 2022)
- Amended and Restated Employment Agreement, dated January 4, 2022, by and between Catalent, Inc. and John R. Chiminski (Filed With SEC on January 5, 2022)
- Employment Agreement, dated January 4, 2022, by and between Catalent, Inc. and Alessandro Maselli (Filed With SEC on January 5, 2022)
- Form of Management Incentive Plan for the fiscal year ending June 30, 2022 (Filed With SEC on November 2, 2021)
- Form of Management Incentive Plan for the fiscal year ending June 30, 2021 (Filed With SEC on November 3, 2020)
- Second Amendment to Employment Agreement, dated August 11, 2020, by and between Catalent, Inc. and John R. Chiminski (Filed With SEC on August 31, 2020)
- Form of Management Incentive Plan for the fiscal year ending June 30, 2020 (Filed With SEC on November 5, 2019)
- Form of 2018 OIP Performance Share Unit Agreement for Non-U.S. Employees (Filed With SEC on November 5, 2019)
- Form of 2018 OIP Performance Share Unit Agreement for U.S. Employees (Filed With SEC on November 5, 2019)
- Summary of Management Incentive Plan for the fiscal year ended June 30, 2019 (Filed With SEC on August 27, 2019)
- Option Grant Notice, dated May 17, 2019, to Pete Buzy (retention grant) (Filed With SEC on August 27, 2019)
- Terms and Conditions of Employment Statement, dated February 1, 2018, between Alessandro Maselli and Catalent Pharma Solutions (Filed With SEC on August 27, 2019)
- Catalent, Inc. 2018 Omnibus Incentive Plan with UK Sub-plan (Filed With SEC on February 5, 2019)
- Catalent, Inc. 2018 Omnibus Incentive Plan (Filed With SEC on November 6, 2018)
- Form of Management Incentive Plan for the fiscal year ended June 30, 2018 (Filed With SEC on November 6, 2018)
- Form of Management Incentive Plan for the fiscal year ended June 30, 2018 (Filed With SEC on August 28, 2018)
- Employment Agreement, dated October 4, 2017 between Jonathan Arnold and Catalent Pharma Solutions GmbH (Filed With SEC on August 28, 2018)
- Amendment to the Catalent Pharma Solutions, Inc. Deferred Compensation Plan dated October 16, 2017 (Filed With SEC on November 6, 2017)
- Catalent Pharma Solutions, Inc. Deferred Compensation Plan as amended and restated effective January 1, 2016 (Filed With SEC on November 6, 2017)
- PERFORMANCE RESTRICTED STOCK GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 28, 2017)
- RESTRICTED STOCK GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 28, 2017)
- AMENDMENT TO EMPLOYMENT AGREEMENT (John R. Chiminski) (Filed With SEC on August 28, 2017)
- Form of Management Incentive Plan for the fiscal year ended June 30, 2017 (Filed With SEC on August 28, 2017)
- Catalent Pharma Solutions, Inc. Deferred Compensation Plan as amended and restated effective January 1, 2017 (Filed With SEC on August 28, 2017)
